Global Avian Influenza Vaccines Market Growth 2025-2031

Global Avian Influenza Vaccines Market Growth 2025-2031

The global Avian Influenza Vaccines market size is predicted to grow from US$ 1076 million in 2025 to US$ 1501 million in 2031; it is expected to grow at a CAGR of 5.7% from 2025 to 2031.

Avian influenza refers to the disease caused by infection with avian (bird) influenza (flu) Type A viruses. These viruses occur naturally among wild aquatic birds worldwide and can infect domestic poultry and other bird and animal species. Avian flu viruses do not normally infect humans. However, sporadic human infections with avian flu viruses have occurred.Avian Influenza Vaccines is a kind of vaccine used to prevent infection caused by Avian Influenza bacteria.

The avian influenza vaccines market is driven by the increasing prevalence of avian flu outbreaks, which pose significant threats to both poultry industries and public health. As global poultry consumption rises, the need to protect livestock from highly pathogenic avian influenza strains is critical to maintaining food security and preventing economic losses. Governments and regulatory bodies are increasingly focused on preventing zoonotic transmission, leading to the widespread use of vaccines in poultry farms. Additionally, ongoing advancements in vaccine development, such as more effective and faster-acting vaccines, are further driving market growth.

A major challenge in the avian influenza vaccines market is the high cost and logistical difficulties of mass vaccination programs, especially in large-scale poultry farms or regions with limited veterinary infrastructure. The need for continuous monitoring and re-vaccination due to the evolving nature of avian influenza strains adds to the complexity and cost of vaccine deployment. Additionally, regulatory barriers and varying standards for vaccine approval across different countries can hinder the global distribution of vaccines, limiting market expansion in certain regions.

Global Avian Influenza Vaccines key players include Boehringer Ingelheim, CAHIC, DHN, HVRI, etc. Global top five manufacturers hold a share over 70%. China is the largest market, with a share about 45%. In terms of product, Type H5 is the largest segment, with a share over 70%. And in terms of application, the largest application is Chicken, followed by Duck and Goose, etc.

LP Information, Inc. (LPI) ' newest research report, the “Avian Influenza Vaccines Industry Forecast” looks at past sales and reviews total world Avian Influenza Vaccines sales in 2024, providing a comprehensive analysis by region and market sector of projected Avian Influenza Vaccines sales for 2025 through 2031. With Avian Influenza Vaccines sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Avian Influenza Vaccines industry.

This Insight Report provides a comprehensive analysis of the global Avian Influenza Vaccines landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Avian Influenza Vaccines portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Avian Influenza Vaccines market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Avian Influenza Vaccines and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Avian Influenza Vaccines.

This report presents a comprehensive overview, market shares, and growth opportunities of Avian Influenza Vaccines market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
H5+H7 Avian Influenza Vaccines
H9 Avian Influenza Vaccines

Segmentation by Application:
Chicken
Duck & Goose
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Boehringer Ingelheim
CAHIC
DHN
HVRI
CEVA
Elanco Animal Health
Zoetis
FATRO
Kyoto Biken
CAVAC
Ringpu Biology
Vaksindo
Sindh Poultry Vaccine Centre
Merck Animal Health
PT Medion Farma Jaya
Avimex Animal Health
JOVAC
Bio-Labs
Pusvetma
IPB-Shigeta
Medion Farma Jaya
Caprifamarindo

Key Questions Addressed in this Report

What is the 10-year outlook for the global Avian Influenza Vaccines market?

What factors are driving Avian Influenza Vaccines market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Avian Influenza Vaccines market opportunities vary by end market size?

How does Avian Influenza Vaccines break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.